AKT1 and neoplasm: Notably, Akt/NICD1+ Sfrp1 (A/N+Sfrp1) mice developed a smaller tumour load 5 weeks after plasmid injection compared to Akt/NICD1/ Vector (A/N+V) mice (Figure 6I).